Matches in SemOpenAlex for { <https://semopenalex.org/work/W1569821061> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W1569821061 endingPage "321" @default.
- W1569821061 startingPage "315" @default.
- W1569821061 abstract "Fedratinib (SAR302503/TG101348) is a Janus kinase 2 (JAK2)-selective inhibitor developed for treatment of patients with myelofibrosis. The effect of food intake on the pharmacokinetics (PKs) and tolerability of single-dose fedratinib was investigated in two Phase I studies (FED12258: 100 mg or 500 mg under fasted or fed [high-fat breakfast] conditions; ALI13451: 500 mg under fasted or fed [low- or high-fat breakfast] conditions) in healthy male subjects. At the 500 mg dose the fed:fasted ratio estimate for area under the plasma concentration-time curve extrapolated to infinity was 0.96 (100 mg; high-fat/fasted), 1.19-1.24 (500 mg; high-fat/fasted), and 1.22 (500 mg; low-fat/fasted). Fedratinib 500 mg attained peak plasma concentration 4 hours after a high-fat breakfast and 2-2.5 hours after a low-fat breakfast or under fasted conditions; terminal half-life was 76-88 hours (fasted) and 73-78 hours (fed). The most frequent adverse events were mild gastrointestinal toxicities, the incidence of which decreased following a high-fat breakfast compared with both fasted and low-fat breakfast conditions (17%, 67%, and 59% of subjects, respectively, in ALI13451). In conclusion, food intake had minimal impact on the PKs of fedratinib, and the tolerability of this drug was improved when taken following a high-fat breakfast." @default.
- W1569821061 created "2016-06-24" @default.
- W1569821061 creator A5009983208 @default.
- W1569821061 creator A5014817660 @default.
- W1569821061 creator A5041620286 @default.
- W1569821061 creator A5046780897 @default.
- W1569821061 creator A5066250890 @default.
- W1569821061 creator A5074140059 @default.
- W1569821061 creator A5081966602 @default.
- W1569821061 date "2014-10-27" @default.
- W1569821061 modified "2023-10-16" @default.
- W1569821061 title "Effect of food on the bioavailability and tolerability of the JAK2-selective inhibitor fedratinib (SAR302503): Results from two phase I studies in healthy volunteers" @default.
- W1569821061 cites W1921435604 @default.
- W1569821061 cites W2014442937 @default.
- W1569821061 cites W2023680965 @default.
- W1569821061 cites W2028803880 @default.
- W1569821061 cites W2048247098 @default.
- W1569821061 cites W2050566930 @default.
- W1569821061 cites W2105496815 @default.
- W1569821061 cites W2127559749 @default.
- W1569821061 cites W2326795317 @default.
- W1569821061 cites W240698351 @default.
- W1569821061 cites W2549906303 @default.
- W1569821061 cites W2614920145 @default.
- W1569821061 cites W3148505026 @default.
- W1569821061 doi "https://doi.org/10.1002/cpdd.161" @default.
- W1569821061 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27136912" @default.
- W1569821061 hasPublicationYear "2014" @default.
- W1569821061 type Work @default.
- W1569821061 sameAs 1569821061 @default.
- W1569821061 citedByCount "28" @default.
- W1569821061 countsByYear W15698210612017 @default.
- W1569821061 countsByYear W15698210612019 @default.
- W1569821061 countsByYear W15698210612020 @default.
- W1569821061 countsByYear W15698210612021 @default.
- W1569821061 countsByYear W15698210612022 @default.
- W1569821061 countsByYear W15698210612023 @default.
- W1569821061 crossrefType "journal-article" @default.
- W1569821061 hasAuthorship W1569821061A5009983208 @default.
- W1569821061 hasAuthorship W1569821061A5014817660 @default.
- W1569821061 hasAuthorship W1569821061A5041620286 @default.
- W1569821061 hasAuthorship W1569821061A5046780897 @default.
- W1569821061 hasAuthorship W1569821061A5066250890 @default.
- W1569821061 hasAuthorship W1569821061A5074140059 @default.
- W1569821061 hasAuthorship W1569821061A5081966602 @default.
- W1569821061 hasConcept C112705442 @default.
- W1569821061 hasConcept C126322002 @default.
- W1569821061 hasConcept C134018914 @default.
- W1569821061 hasConcept C181389837 @default.
- W1569821061 hasConcept C197934379 @default.
- W1569821061 hasConcept C2778375690 @default.
- W1569821061 hasConcept C71924100 @default.
- W1569821061 hasConcept C98274493 @default.
- W1569821061 hasConceptScore W1569821061C112705442 @default.
- W1569821061 hasConceptScore W1569821061C126322002 @default.
- W1569821061 hasConceptScore W1569821061C134018914 @default.
- W1569821061 hasConceptScore W1569821061C181389837 @default.
- W1569821061 hasConceptScore W1569821061C197934379 @default.
- W1569821061 hasConceptScore W1569821061C2778375690 @default.
- W1569821061 hasConceptScore W1569821061C71924100 @default.
- W1569821061 hasConceptScore W1569821061C98274493 @default.
- W1569821061 hasIssue "4" @default.
- W1569821061 hasLocation W15698210611 @default.
- W1569821061 hasLocation W15698210612 @default.
- W1569821061 hasOpenAccess W1569821061 @default.
- W1569821061 hasPrimaryLocation W15698210611 @default.
- W1569821061 hasRelatedWork W1555144605 @default.
- W1569821061 hasRelatedWork W1970245702 @default.
- W1569821061 hasRelatedWork W1970331292 @default.
- W1569821061 hasRelatedWork W2004325424 @default.
- W1569821061 hasRelatedWork W2074207917 @default.
- W1569821061 hasRelatedWork W2080955156 @default.
- W1569821061 hasRelatedWork W2379311614 @default.
- W1569821061 hasRelatedWork W2400119402 @default.
- W1569821061 hasRelatedWork W2606334551 @default.
- W1569821061 hasRelatedWork W2776273895 @default.
- W1569821061 hasVolume "4" @default.
- W1569821061 isParatext "false" @default.
- W1569821061 isRetracted "false" @default.
- W1569821061 magId "1569821061" @default.
- W1569821061 workType "article" @default.